A cross-sectional study to determine whether certain microbiome on the skin influence the progression of sun-damaged skin to skin cancer in immune-supressed transplant recipients.

The University of Queensland0 个研究点目标入组 300 人开始时间: 2016年7月5日最近更新: 2020年1月13日

适应症

试验速览

暂无简介。

•All participants in the study will need to have been immune-suppressed for over 1 year as a result of a kidney or liver transplant, prior to enrolling in the study. They will also need to be over the age of 40 years old. Participants are divided into three specific groups based on whether they have current SCCs (anywhere on the body) or AKs (on either forearm).
•There will be 3 distinct groups recruited;
•1. Renal/liver transplant recipients with over 1 year of immune-suppression, with no AKs
•2. Renal/liver transplant recipients with over 1 year of immune-suppression, with at least 2 AKs on one forearm.
•3. Renal/liver transplant recipients with over 1 year of immune-suppression, with one SCC located anywhere on the body.

•Topical medicated creams to the area being sampled i.e. 5-fluorouracil, imiquimod, diclofenac sodium, ingenol mebutate, PDT, corticosteroid. Topical keratolytics.

发起方